Drug profile · INN
sacrosidase
SUCRAID
sacrosidase (SUCRAID) is a sucrose hydrolytic enzyme. Route of administration: oral. Current US regulatory status: approved.
FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — sacrosidase
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
sacrosidase (SUCRAID) is a sucrose hydrolytic enzyme. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN sacrosidase
Brand SUCRAID
Mechanism Sucrose hydrolytic enzyme
Target Sucrose
Route ORAL
Formulation SOLUTION
Mechanism of action
Sucrose hydrolytic enzyme
Primary target: Sucrose
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is sacrosidase?
sacrosidase (SUCRAID) is a sucrose hydrolytic enzyme. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for sacrosidase?
SUCRAID is a marketed brand name for sacrosidase. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of sacrosidase?
sacrosidase has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.